Cosmax, Inc.

KOSE:A192820 Stock Report

Market Cap: ₩1.7t

Cosmax Valuation

Is A192820 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of A192820 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: A192820 (₩150800) is trading below our estimate of fair value (₩378191.82)

Significantly Below Fair Value: A192820 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for A192820?

Key metric: As A192820 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for A192820. This is calculated by dividing A192820's market cap by their current earnings.
What is A192820's PE Ratio?
PE Ratio21.9x
Earnings₩78.68b
Market Cap₩1.74t

Price to Earnings Ratio vs Peers

How does A192820's PE Ratio compare to its peers?

The above table shows the PE ratio for A192820 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average44.3x
A161890 Kolmar Korea
130.9x61.5%₩1.3t
A018290 VT
18.6xn/a₩1.5t
A002790 AMOREPACIFIC Group
7.7x3.2%₩1.8t
A278470 APR
19.9x24.0%₩1.8t
A192820 Cosmax
21.7x27.1%₩1.7t

Price-To-Earnings vs Peers: A192820 is good value based on its Price-To-Earnings Ratio (21.7x) compared to the peer average (44.3x).

Price to Earnings Ratio vs Industry

How does A192820's PE Ratio compare vs other companies in the KR Personal Products Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
A900120 CXI Healthcare Technology Group
0.7xn/aUS$14.08m
No more companies available in this PE range
A192820 21.9xIndustry Avg. 16.7xNo. of Companies5PE01224364860+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: A192820 is expensive based on its Price-To-Earnings Ratio (21.7x) compared to the KR Personal Products industry average (16.7x).

Price to Earnings Ratio vs Fair Ratio

What is A192820's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

A192820 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio21.9x
Fair PE Ratio20x

Price-To-Earnings vs Fair Ratio: A192820 is expensive based on its Price-To-Earnings Ratio (21.7x) compared to the estimated Fair Price-To-Earnings Ratio (20x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst A192820 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current₩150,800.00
₩188,900.00
+25.3%
10.3%₩239,000.00₩160,000.00n/a20
Dec ’25₩133,000.00
₩190,857.14
+43.5%
10.9%₩239,000.00₩160,000.00n/a21
Nov ’25₩153,200.00
₩190,833.33
+24.6%
11.5%₩239,000.00₩160,000.00n/a18
Oct ’25₩146,000.00
₩191,000.00
+30.8%
11.7%₩239,000.00₩160,000.00n/a17
Sep ’25₩121,300.00
₩191,687.50
+58.0%
12.0%₩239,000.00₩160,000.00n/a16
Aug ’25₩154,000.00
₩217,062.50
+40.9%
10.3%₩250,000.00₩179,000.00n/a16
Jul ’25₩189,100.00
₩202,062.50
+6.9%
8.9%₩239,000.00₩170,000.00n/a16
Jun ’25₩170,000.00
₩198,875.00
+17.0%
8.3%₩230,000.00₩170,000.00n/a16
May ’25₩140,100.00
₩173,625.00
+23.9%
11.4%₩223,000.00₩124,000.00n/a16
Apr ’25₩130,000.00
₩164,937.50
+26.9%
9.1%₩180,000.00₩124,000.00n/a16
Mar ’25₩107,600.00
₩173,250.00
+61.0%
7.2%₩200,000.00₩145,000.00n/a16
Feb ’25₩113,700.00
₩173,250.00
+52.4%
7.2%₩200,000.00₩145,000.00n/a16
Jan ’25₩126,400.00
₩172,062.50
+36.1%
7.2%₩200,000.00₩145,000.00n/a16
Dec ’24₩112,100.00
₩164,058.82
+46.4%
15.1%₩200,000.00₩100,000.00₩133,000.0017
Nov ’24₩133,600.00
₩163,533.33
+22.4%
15.7%₩200,000.00₩100,000.00₩153,200.0015
Oct ’24₩128,700.00
₩158,928.57
+23.5%
16.7%₩192,000.00₩100,000.00₩146,000.0014
Sep ’24₩151,800.00
₩157,500.00
+3.8%
16.4%₩192,000.00₩100,000.00₩121,300.0014
Aug ’24₩101,900.00
₩118,714.29
+16.5%
10.7%₩141,000.00₩100,000.00₩154,000.0014
Jul ’24₩93,000.00
₩109,214.29
+17.4%
12.7%₩130,000.00₩70,000.00₩189,100.0014
Jun ’24₩81,100.00
₩108,142.86
+33.3%
12.1%₩130,000.00₩70,000.00₩170,000.0014
May ’24₩77,200.00
₩99,916.67
+29.4%
11.7%₩115,000.00₩70,000.00₩140,100.0012
Apr ’24₩81,000.00
₩99,500.00
+22.8%
11.8%₩115,000.00₩70,000.00₩130,000.0012
Mar ’24₩77,300.00
₩87,923.08
+13.7%
16.0%₩115,000.00₩65,000.00₩107,600.0013
Feb ’24₩78,400.00
₩88,428.57
+12.8%
14.9%₩107,000.00₩65,000.00₩113,700.0014
Jan ’24₩74,100.00
₩76,461.54
+3.2%
14.6%₩103,000.00₩65,000.00₩126,400.0013
Dec ’23₩63,300.00
₩77,428.57
+22.3%
16.9%₩103,000.00₩60,000.00₩112,100.0014

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 12:25
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Cosmax, Inc. is covered by 37 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hyung-Joon MoonBarclays
Hyeryeong KimCGS International
Hyunah JoCGS International